Media ReleasesNews & Events
Lorraine Driscoll, a senior executive with extensive experience in state and local governments, associations and private enterprise, has been appointed to the Board of the Harry Perkins Institute of Medical…
Epigenetics and Genomics LaboratoryFundingGenome Biology and Genetic DiseasesLabMedia ReleasesNews & EventsResearch
Perkins researchers granted funds to advance epigenetic research
By Richard Schoonraad | Epigenetics and Genomics Laboratory, Funding, Genome Biology and Genetic Diseases, Lab, Media Releases, News & Events, ResearchTwo researchers at the Harry Perkins Institute of Medical Research have been awarded separate grants totalling $3.6million in federal government funding to better understand and treat diseases. Perkins CEO, Prof…
Breast CancerBreast CancerCancerCancerDisease AreaEventsFundraisingNews & EventsOvarian Cancer
1000 walkers raise over $1.45m for women’s cancer research
By Richard Schoonraad | Breast Cancer, Breast Cancer, Cancer, Cancer, Disease Area, Events, Fundraising, News & Events, Ovarian CancerTaking steps to reduce the devastating impact of cancer on women. Fast Facts On average 69,000 new cases of cancer are diagnosed in Australian women each year. One in two…
Molecular Endocrinology and PharmacologyNews & Events
Biodesign program wins national award for excellence
By Richard Schoonraad | Molecular Endocrinology and Pharmacology, News & EventsA program that provides industry engagement opportunities and training in biomedical design thinking, while giving industry access to research talent has won a national award. iPREP Biodesign, administered by The…
CancerCancerCancer and Cell BiologyGenetic DiseaseGenetic DiseaseGenome Biology and Genetic DiseasesLabNews & EventsOvarian CancerResearchTumours
“Google map” of ovarian tumours reveals cancer cells control who gets into their neighbourhood
By Richard Schoonraad | Cancer, Cancer, Cancer and Cell Biology, Genetic Disease, Genetic Disease, Genome Biology and Genetic Diseases, Lab, News & Events, Ovarian Cancer, Research, TumoursPerth researchers find some ovarian cancer cells appear to tell immune system to stay away. “Spatial transcriptomics reveals discrete tumour microenvironments and autocrine loops within ovarian cancer subclones” published in…
News & Events
Excitement is palpable among Harry Perkins Institute researchers as they progress the approval stages of a drug that may have the damaging peripheral artery disease on the run. First published…
Chronic Kidney DiseaseKidney DiseaseLabMedia ReleasesMolecular Endocrinology and PharmacologyNews & EventsResearchResearch Area
Phase 3 drug trial for rare chronic kidney disease achieves key milestone
By Richard Schoonraad | Chronic Kidney Disease, Kidney Disease, Lab, Media Releases, Molecular Endocrinology and Pharmacology, News & Events, Research, Research AreaBiopharmaceutical company, Dimerix Limited (ASX: DXB, “Dimerix”), which is developing new treatments for types of inflammatory kidney and respiratory diseases, has announced successful interim results of a Phase 3 trial…
FundingFundraisingMedia ReleasesNews & EventsPerkins Events
Fundraising value recognised with two national awards
By Richard Schoonraad | Funding, Fundraising, Media Releases, News & Events, Perkins EventsPerth’s Harry Perkins Institute of Medical Research is very proud to announce it brought home two category awards from the Fundraising Institute of Australia’s National Awards for Excellence in Fundraising,…
